Back to DE D. E. Shaw & Co., Inc.
SUPN30 quarters
Position history for DED. E. Shaw & Co., Inc.'s holdings in SUPERNUS PHARMACEUTICALS
D. E. Shaw & Co., Inc. holds 767,668 shares of SUPN (SUPERNUS PHARMACEUTICALS), worth $35.7M as of 2026-Q2. The position was increased (+23.3% shares). SUPN represents 0.0% of D. E. Shaw & Co., Inc.'s portfolio.
Current Value
$35.7M
Current Shares
767,668
Total Value Change
+$33.9M
Total Shares Change
+714,766
Quarter-by-Quarter History
Other major holders of SUPN: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc.